Class A61P : THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
Subclass 3/08: Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) for glucose homeostasis (pancreatic hormones A61P 5/48)
| Patent # | Title | Filing Date | Issue Date | Patent Owner |
|---|---|---|---|---|
| 12252703 | Closed-ended linear duplex DNA for non-viral gene transfer | Jun 01, 21 | Mar 18, 25 | UNIVERSITY OF MASSACHUSETTS; Voyager Therapeutics, Inc.; |
| 12239660 | Therapeutic composition and methods | Sep 25, 23 | Mar 04, 25 | Viscera Labs, Inc. |
| 12233125 | Method for treating pulmonary hypertension with antibodies to human Resistin | Oct 22, 20 | Feb 25, 25 | The Johns Hopkins University |
| 12220444 | Treatment of hyperinsulinemic hypoglycemia with GLP-1 antagonist exendin(9-39) | Feb 22, 23 | Feb 11, 25 | The Board of Trustees of the Leland Stanford Junior University |
| 12133545 | Plant-soaked solution comprising tagatose, and method for producing same | Jun 23, 17 | Nov 05, 24 | CJ CHEILJEDANG CORPORATION |
| 12134636 | Immunoglobulins and uses thereof | Oct 30, 20 | Nov 05, 24 | Janssen Pharmaceutica NV |
| 12102663 | Treatment of post-bariatric hypoglycemia with exendin (9-39) | Feb 22, 23 | Oct 01, 24 | The Board of Trustees of the Leland Stanford Junior University |
| 12059403 | Use of SWELL1 inhibitors and modulators to treat type 2 diabetes and obesity | Aug 04, 17 | Aug 13, 24 | The University of Iowa Research Foundation |
| 12059440 | Preparation and application of grain worm for treating diabetes | Aug 23, 21 | Aug 13, 24 | Not available |
| 12048313 | Combination of 25-hydroxyvitamin D and antioxidants/anti-inflammatories for poultry ovarian health | Mar 24, 22 | Jul 30, 24 | DSM IP Assets B. V. |
| 12042472 | Sublingual epinephrine tablets | Jan 13, 22 | Jul 23, 24 | pHase Pharmaceuticals LLC |
| 12029774 | Açai berry seed extract, fractions of açai berry seed extracts, process for obtaining açai berry seed extracts, pharmaceutical and food compositions and method for the treatment of diseases or disorders with açai berry seed extract | Jul 18, 22 | Jul 09, 24 | Power Seed Comércio e Representações Ltda; UERJ—Universidade do Estado do Rio de Janeiro; |
| 12005265 | Compositions and methods to modulate cell activity | Aug 06, 20 | Jun 11, 24 | The Rockefeller University; Rensselaer Polytechnic Institute; |
| 11969411 | Administration of berberine metabolites | Jun 07, 21 | Apr 30, 24 | AXCESS GLOBAL SCIENCES, LLC |
| 11963974 | Antisense oligonucleotide and composition for prevention or treatment of glycogen storage disease type Ia | Mar 09, 18 | Apr 23, 24 | NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT; Hiroshima University; DAIICHI SANKYO COMPANY, LIMITED; |
| 11938126 | Method of treating diseases of the visual system | Jun 28, 22 | Mar 26, 24 | MyMD Pharmaceuticals, Inc. |
| 11919891 | Bicyclic compounds useful as GPR120 modulators | Dec 14, 20 | Mar 05, 24 | Valo Health, Inc. |
| 11840527 | Non-fused thiophene derivatives and their uses | Feb 08, 19 | Dec 12, 23 | ENYO PHARMA |
| 11821013 | Blood glucose stabilizing methods and compositions | Mar 15, 23 | Nov 21, 23 | Digestiva, Inc. |
| 11813258 | Therapy for mitochondrial fatty acid beta-oxidation and transport disorders | Jun 10, 21 | Nov 14, 23 | University of Pittsburgh—of the Commonwealth System of Higher Education |
| Publication # | Title | Filing Date | Pub Date | Patent Owner |
|---|---|---|---|---|
| 2025/0114,424 | PLANT EXTRACT-BASED COMPOSITION AND ITS USE FOR TREATING GLUCOSE METABOLISM DISORDERS | Aug 04, 22 | Apr 10, 25 | ESSERRE PHARMA SRL |
| 2025/0090,684 | POLYNUCLEOTIDES ENCODING GLUCOSE-6-PHOSPHATASE FOR THE TREATMENT OF GLYCOGEN STORAGE DISEASE TYPE 1A (GSD1A) | Jul 26, 22 | Mar 20, 25 | Not available |
| 2025/0092,025 | GPCR RECEPTOR AGONISTS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, AND METHODS FOR THEIR USE | Apr 11, 24 | Mar 20, 25 | Not available |
| 2025/0082,730 | TREATMENT OF POST-BARIATRIC HYPOGLYCEMIA WITH EXENDIN (9-39) | Jun 17, 24 | Mar 13, 25 | The Board of Trustees of the Leland Stanford Junior University |
| 2025/0075,168 | METHOD FOR REGULATING BLOOD GLUCOSE, LOSING WEIGHT, AND REDUCING PRODUCTION OF ADVANCED GLYCATION END PRODUCTS BY USING SACCHAROMYCES CEREVISIAE TCI907 AND/OR METABOLITE THEREOF | Jan 25, 24 | Mar 06, 25 | Not available |
| 2025/0026,803 | IMMUNOGLOBULINS AND USES THEREOF | Oct 02, 24 | Jan 23, 25 | Not available |
| 2024/0366,533 | Sublingual Epinephrine Tablets | Jul 19, 24 | Nov 07, 24 | Not available |
| 2024/0368,644 | METHODS TO PRODUCE THERAPEUTIC FORMULATIONS COMPRISING HYDROXYBUTIRATE AND HYDROXYVALERATE, THERAPEUTIC FORMULATIONS AND USES THEREOF | Jun 23, 22 | Nov 07, 24 | PHB Industrial S.A.; VitaNav, Inc.; |
| 2024/0327,459 | PEPTIDE FRAGMENTS FOR TREATMENT OF DIABETES | Jun 17, 24 | Oct 03, 24 | Follicum AB |
| 2024/0307,501 | TREATMENT OF CONGENITAL HYPERINSULINISM WITH AVEXITIDE | Jun 21, 22 | Sep 19, 24 | Eiger BioPharmaceuticals, Inc. |
| 2024/0294,587 | K-RAS INHIBITOR | Mar 21, 22 | Sep 05, 24 | Not available |
| 2024/0277,816 | POLYPEPTIDE CONJUGATE AND APPLICATION THEREOF IN PREPARATION OF DRUG FOR TREATING DISEASES RELATED TO GLUCOSE METABOLISM | Jul 20, 22 | Aug 22, 24 | PEGBIO CO., LTD. |
| 2024/0279,298 | GLUCAGON ANALOG AND MEDICAL USE THEREOF | Jun 17, 22 | Aug 22, 24 | Not available |
| 2024/0252,492 | GPCR RECEPTOR AGONISTS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, AND METHODS FOR THEIR USE | Jan 27, 22 | Aug 01, 24 | Not available |
| 2024/0238,234 | COMPOSITION FOR PREVENTING OR TREATING OBESITY COMPRISING POLY-y-GLUTAMIC ACID ISOLATED FROM BACILLUS AS ACTIVE INGREDIENT | Oct 03, 23 | Jul 18, 24 | Pukyong National University Industry-University Cooperation Foundation |
| 2024/0207,204 | Treatment Of Type 2 Diabetes With Hepatocyte Nuclear Factor 4 Alpha (HNF4A) Agonists | Dec 11, 23 | Jun 27, 24 | Not available |
| 2024/0207,235 | NANOEMULSION FORMULATION FOR TREATING DISBETES MELLITUS (DM) | Dec 22, 22 | Jun 27, 24 | Not available |
| 2024/0158,382 | Agonists Of Free Fatty Acid Receptor 1 And Their Use In Diseases Associated With Said Receptor | Oct 20, 20 | May 16, 24 | Not available |
| 2024/0139,262 | COMPLEX PROBIOTIC COMPOSITION AND METHOD FOR IMPROVING EXERCISE PERFORMANCE OF SUBJECT WITH LOW INTRINSIC AEROBIC EXERCISE CAPACITY | Oct 13, 23 | May 02, 24 | Not available |
| 2024/0139,129 | NOVEL METHOD AND AGENT FOR TREATING, DIAGNOSING AND DETECTING DIABETES AND COMPLICATIONS | Feb 25, 22 | May 02, 24 | Not available |
| Upgrade to the Professional Level to view Top Owners for this Subclass.Learn More |
|---|
